SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Rabbit PAb, Antigen Affinity Purified General Information
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Rabbit PAb, Antigen Affinity Purified Validated Applications
Application | Dilution |
---|---|
WB | 1:1000-1:5000 |
ELISA | 1:5000-1:10000 |
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Rabbit PAb, Antigen Affinity Purified Images
-NPh-RP02-HD14MA0914-WB.png)
Anti-SARS-NP rabbit polyclonal antibody at 1:2000 dilution.
Lane A: SARS-CoV NP Protein (Cat#40143-V08B) (30ng)
Lane B: SARS-CoV NP Protein (Cat#40143-V08B) (5ng)
Lane C: SARS-CoV-2 (2019-nCoV) NP Protein (Cat#40588-V08B) (10ng)
Lane D: SARS-CoV-2 (2019-nCoV) NP Protein (Cat#40588-V08B) (5ng)
Secondary
Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution.
Developed using the ECL technique.
Performed under reducing conditions.
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Rabbit PAb, Antigen Affinity Purified: Synonyms
Coronavirus Nucleocapsid Background Information
- 1.Van Boheemen S, et al. (2012),MBio. 3(6):e00473-12.
- Bisht H. et al., 2004,Proc Natl Acad Sci. 101 (17): 6641-6.
- Li W. et al., 2005,Science.309 (5742): 1864-8.
- Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19AuthorLiu, X;Li, Z;Liu, S;Sun, J;Chen, Z;Jiang, M;Zhang, Q;Wei, Y;Wang, X;Huang, YY;Shi, Y;Xu, Y;Xian, H;Bai, F;Ou, C;Xiong, B;Lew, AM;Cui, J;Fang, R;Huang, H;Zhao, J;Hong, X;Zhang, Y;Zhou, F;Luo, HB;Year2020JournalActa Pharm Sin BApplicationFoci forming assayPubMed ID: 32318327FoldedExpand
- COVID-19 Severity Correlates with Weaker T Cell Immunity, Hypercytokinemia and Lung Epithelium InjuryAuthorWang, Z;Yang, X;Zhou, Y;Sun, J;Liu, X;Zhang, J;Mei, X;Zhong, J;Zhao, J;Ran, P;Year2020JournalAm. J. Respir. Crit. Care Med.PubMed ID: 32608999FoldedExpand
- Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications on COVID-19 immunityAuthorMcAndrews, KM;Dowlatshahi, DP;Dai, J;Becker, LM;Hensel, J;Snowden, LM;Leveille, JM;Brunner, MR;Holden, K;Hopkins, NS;Harris, A;Kumpati, JJ;Whitt, MA;Lee, JJ;Ostrosky-Zeichner, L;Papanna, R;LeBleu, V;Allison, J;Kalluri, R;Year2020JournalJCI InsightPubMed ID: 32796155FoldedExpand
- SARS-CoV-2 and three related coronaviruses utilize multiple ACE2 orthologs and are potently blocked by an improved ACE2-IgAuthorLi, Y;Wang, H;Tang, X;Fang, S;Ma, D;Du, C;Wang, Y;Pan, H;Yao, W;Zhang, R;Zou, X;Zheng, J;Xu, L;Farzan, M;Zhong, G;Year2020JournalJ. Virol.PubMed ID: 32847856FoldedExpand
If you couldn"t find the specific citation, you can:
- Find All Citations
- Submit a CitationGet a Publication Reward
- Leave Us a Message
Recombinant Antibody Production Service
High-throughput Recombinant Antibody Production
Large-scale Antibody Production
Antibody Development Service
Rabbit MAb Production Service
Mouse MAb Production Service
Rabbit PAb Production Service
Phospho-Specific Antibody
Anti-Idiotype Antibody
Fast Antibody Development Service
Mouse MAb
Rabbit PAb
More Antibody Production Service
Hybridoma Antibody Production
Chimeric Antibody
Antibody Fragment
Bispecific Antibody
We also have Immunoassay Service. Click to see more.